Results 101 to 110 of about 19,722 (182)

Oncogenic gene fusions in cancer: from biology to therapy. [PDF]

Signal Transduct Target Ther
Liu SV, Nagasaka M, Atz J, Solca F, Müllauer L.   +4 more
europepmc   +1 more source

Chronic myelogenous leukemia coexpressing V-e16a2, V-e13a2, e13a2, and e14a2 BCR::ABL1 fusion transcripts: a case report and review of the literature. [PDF]

Front Oncol
Xu Y, Fan Y, Liu S, Chang J, Guo C, Chen L, Guo W, Dang J, Wang H, Tan Y.   +9 more
europepmc   +1 more source

Improving the Diagnosis and Follow-Up of Chronic Myeloid Leukemia Using Conventional and Molecular Techniques. [PDF]

J Clin Lab Anal
Bahar NAA, Al-Ouqaili MTS, Talib NM.
europepmc   +1 more source

Utility of the Base Editing System for Introducing Drug-Resistant Gene Mutations Into Human Leukemia Cellular Models. [PDF]

Cureus
Nguyen T, Tamai M, Fujisawa S, Nagamachi A, Kagami K, Komatsu C, Iwamoto S, Inaba T, Teshima T, Inukai T.   +9 more
europepmc   +1 more source

Treatment-Emergent Resistance to Asciminib in Chronic Myeloid Leukemia Patients Due to Myristoyl-Binding Pocket-Mutant of <i>BCR::ABL1/A337V</i> Can Be Effectively Overcome with Dasatinib Treatment. [PDF]

Curr Oncol
Batar P, Mezei G, Illes A.
europepmc   +1 more source

Tyrosine kinase inhibitors modulate the expression of peroxiredoxins 1 and 2 in chronic myeloid leukemia cells. [PDF]

Leuk Res Rep
Kazama H, Wang YH, Tanaka J.
europepmc   +1 more source

Development of mirror-image monobodies targeting the oncogenic BCR::ABL1 kinase. [PDF]

Nat Commun
Schmidt N, Kumar A, Korf L, Dinh-Fricke AV, Abendroth F, Koide A, Linne U, Rakwalska-Bange M, Koide S, Essen LO, Vázquez O, Hantschel O.   +11 more
europepmc   +1 more source

COVID-19 mitigates the response to TKIs in patients with CML via the inhibition of T-cell immunity. [PDF]

Front Immunol
He N, Li G, Liu J, Liu W, Tian R, Ma D.
europepmc   +1 more source

Sustained treatment-free remission in two chronic myeloid leukemia patients after asciminib discontinuation: a report of two cases. [PDF]

Ann Hematol
Yousefi A, Levin MD, Cornelissen JJ, Westerweel PE.   +3 more
europepmc   +1 more source

Role of c-ABL in DENV-2 Infection and Actin Remodeling in Vero Cells. [PDF]

Int J Mol Sci
Carreño-Flórez GP, Cuartas-López AM, Boudreau RL, Vicente-Manzanares M, Gallego-Gómez JC.   +4 more
europepmc   +1 more source